Skip to main content
. Author manuscript; available in PMC: 2015 Jan 5.
Published in final edited form as: Clin Cancer Res. 2010 Aug 18;16(19):4899–4905. doi: 10.1158/1078-0432.CCR-10-0832

Table 1. Patient baseline characteristics.

No. of patients (%)
ECOG performance status:
0 16 (40)
1 18 (45)
2 6 (15)
Primary site:
Ovary 35 (88)
Primary peritoneal 4 (10)
Missing 1 (3)
Age at registration (years):
<60 10 (25)
60-69.9 23 (58)
70+ 7 (18)
Median age: 64.3 (range: 47.5-80.1) years
Measurable disease, according to RECIST criteria:
Yes 35 (88)
No (no measured target lesions) 5 (13)
Previous anticancer therapy:
No. of prior platinum-contained regimens:
1 27 (68)
2 10 (25)
3+ 2 (5)
Missing 1 (3)